Cargando…

Effects of Initiating or Switching to a Six-Monthly Triptorelin Formulation on Prostate Cancer Patient–Healthcare Interactions and Hospital Resource Use: a Real-World, Retrospective, Non-Interventional Study

INTRODUCTION: Luteinising hormone-releasing hormone agonist (LHRHa) injections are currently used in the treatment of advanced prostate cancer, but the frequency of injections may represent a burden to patients and healthcare services. The aim of this study was to collect real-world evidence about c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cornford, Philip, Jefferson, Kieran, Cole, Owen, Gilbody, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359994/ https://www.ncbi.nlm.nih.gov/pubmed/32700031 http://dx.doi.org/10.1007/s40487-018-0087-1

Ejemplares similares

Impact of 6-month triptorelin formulation on predicted adult height and basal gonadotropin levels in patients with central precocious puberty
por: Yoo, Eunjoo, et al.
Publicado: (2023)

Efficacy and Safety of Triptorelin 3-Month Formulation in Chinese Children with Central Precocious Puberty: A Phase 3, Open-Label, Single-Arm Study
por: Luo, Xiaoping, et al.
Publicado: (2023)

Assessment of Two Formulations of Triptorelin in Chinese Patients with Endometriosis: A Phase 3, Randomized Controlled Trial
por: Li, Xiaoyan, et al.
Publicado: (2022)

Clinical outcome of one-third–dose depot triptorelin is the same as half-dose depot triptorelin in the long protocol of controlled ovarian stimulation
por: Li, Yu, et al.
Publicado: (2012)

Synthesis of Triptorelin Lactate Catalyzed by Lipase in Organic Media
por: Zhuang, Hong, et al.
Publicado: (2012)

380 Presentation of Three Cases of Allergic Reactions to Triptorelin
por: Diaz, Maria Cristina, et al.
Publicado: (2012)

Efficacy of Triptorelin 3-Month Depot Compared to 1-Month Depot for the Treatment of Korean Girls with Central Precocious Puberty in Single Tertiary Center
por: Chung, Lindsey Yoojin, et al.
Publicado: (2021)

Central Precocious Puberty: Treatment with Triptorelin 11.25 mg
por: Chiocca, Elena, et al.
Publicado: (2012)

Evaluation of Hypersensitivity Reactions with Leuprolide Acetate and Triptorelin Acetate in Children
por: Metbulut, Azize Pınar, et al.
Publicado: (2021)

Triptorelin nanoparticle-loaded microneedles for use in assisted reproductive technology
por: Lu, Xiaoyan, et al.
Publicado: (2023)

Simvastatin versus triptorelin in prevention of pain recurrences after surgery for endometriosis
por: Kargar, Mona, et al.
Publicado: (2013)

Preparation and In-vitro Evaluation of Controlled Release PLGA Microparticles Containing Triptoreline
por: Mahboubian, Alireza, et al.
Publicado: (2010)

An Update on Triptorelin: Current Thinking on Androgen Deprivation Therapy for Prostate Cancer
por: Merseburger, Axel S., et al.
Publicado: (2016)

Spotlight on triptorelin in the treatment of premenopausal women with early-stage breast cancer
por: Venturelli, Marta, et al.
Publicado: (2018)

Efficacy of Testosterone Suppression with Sustained-Release Triptorelin in Advanced Prostate Cancer
por: Breul, Jürgen, et al.
Publicado: (2016)

Use of the Subcutaneous Triptorelin Stimulation Test for Diagnosis of Central Precocious Puberty
por: Ahn, Jungmin, et al.
Publicado: (2023)

Healthcare resource use and costs reduction with aripiprazole once-monthly in schizophrenia: AMBITION, a real-world study
por: Sanchez-Gistau, Vanessa, et al.
Publicado: (2023)

Real-world data of six patients with atypical hemolytic uremic syndrome switched to ravulizumab
por: Ehren, Rasmus, et al.
Publicado: (2021)

Six-month depot formulation of leuprorelin acetate in the treatment of prostate cancer
por: Sethi, Rajni, et al.
Publicado: (2009)

Clinical evaluation of laparoscopic surgery combined with triptorelin acetate in patients with endometriosis and infertility
por: Xue, Huiling, et al.
Publicado: (2018)

Effect of triptorelin on lower urinary tract symptoms in Australian prostate cancer patients
por: Woo, Henry H, et al.
Publicado: (2017)

Triptorelin for the treatment of adenomyosis: A multicenter observational study of 465 women in Russia
por: Andreeva, Elena, et al.
Publicado: (2020)

The Anticancer Activity Compared Between Triptorelin and a New Gonadotropin Releasing Hormone Analogue
por: Saleh-Abady, Mohammad Mirzaei, et al.
Publicado: (2009)

Symptom control after different duration of triptorelin treatment following conservative surgery for deep infiltrating endometriosis: Post-hoc analysis of a multicentre, prospective, real-world study
por: Sun, Wenting, et al.
Publicado: (2021)

Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes: A Real-World, Prospective, Non-interventional Study Across Six Countries
por: Fulcher, Gregory R., et al.
Publicado: (2022)

A 43-year-old woman on triptorelin presenting with pseudotumor cerebri: a case report
por: Bhatt, Uday Kumar, et al.
Publicado: (2012)

Triptorelin in the Relief of Lower Urinary Tract Symptoms in Advanced Prostate Cancer Patients: The RESULT Study
por: Peltier, Alexandre, et al.
Publicado: (2015)

Triptorelin stimulated luteinizing hormone concentrations for diagnosing central precocious puberty: study of diagnostic accuracy
por: Vukovic, Rade, et al.
Publicado: (2021)

Mechanistic Study on Triptorelin Action in Protecting From 5-FU-Induced Ovarian Damage in Rats
por: Wang, Ying, et al.
Publicado: (2015)

Leuprolide and triptorelin treatment in children with idiopathic central precocious puberty: an efficacy/tolerability comparison study
por: Valenzise, M., et al.
Publicado: (2023)

Endocrine Responses to Triptorelin in Healthy Women, Women With Polycystic Ovary Syndrome, and Women With Hypothalamic Amenorrhea
por: Abbara, Ali, et al.
Publicado: (2023)

Correction to: Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes: A Real-World, Prospective, Non-interventional Study Across Six Countries
por: Fulcher, Gregory R., et al.
Publicado: (2022)

Six-month leuprorelin acetate depot formulations in advanced prostate cancer: a clinical evaluation
por: Tunn, Ulf W, et al.
Publicado: (2013)

Real-World Reductions in Healthcare Resource Utilization over 6 Months in Patients with Substance Use Disorders Treated with a Prescription Digital Therapeutic
por: Shah, Neel, et al.
Publicado: (2022)

Hypertriglyceridaemia and the risk of pancreatitis six months post lopinavir/ritonavir initiation
por: Greffrath, Wilhelm P., et al.
Publicado: (2018)

Sustained In-Vivo Release of Triptorelin Acetate from a Biodegradable Silica Depot: Comparison to Pamorelin(®) LA
por: Forsback, Ari-Pekka, et al.
Publicado: (2021)

Adjunct Triptorelin in the Treatment of Obsessive-Compulsive Disorder in Clients Receiving Selective Serotonin Reuptake Inhibitors (SSRIs)
por: Nikzad, Faezeh, et al.
Publicado: (2021)

Predictive Factors for Rheumatoid Arthritis Flare After Switching From Intravenous to Subcutaneous Formulation of Tocilizumab in Real-World Practice
por: Ahn, Soo Min, et al.
Publicado: (2022)

Dual trigger of triptorelin and HCG optimizes clinical outcome for high ovarian responder in GnRH-antagonist protocols
por: Li, Saijiao, et al.
Publicado: (2018)

Efficacy and Safety of gonadotropin-releasing hormone (GnRH) Agonists Triptorelin Acetate and Cetrorelix Acetate in Assisted Reproduction
por: Jiang, Jingjing, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_q87omd5jibqscolfnoarv2h4h4